Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Federal Trade Commission
Colorcon
Covington
QuintilesIMS
Fuji
Queensland Health
Accenture
Baxter

Generated: August 15, 2018

DrugPatentWatch Database Preview

Pohl Boskamp Company Profile

« Back to Dashboard

What is the competitive landscape for POHL BOSKAMP, and what generic alternatives to POHL BOSKAMP drugs are available?

POHL BOSKAMP has three approved drugs.

There are two US patents protecting POHL BOSKAMP drugs.

There are seventeen patent family members on POHL BOSKAMP drugs in nine countries.

Summary for Pohl Boskamp
International Patents:17
US Patents:2
Tradenames:5
Ingredients:1
NDAs:3

Drugs and US Patents for Pohl Boskamp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pohl Boskamp NITROLINGUAL PUMPSPRAY nitroglycerin SPRAY, METERED;SUBLINGUAL 018705-002 Jan 10, 1997 AB RX Yes Yes 7,872,049 ➤ Try a Free Trial Y ➤ Try a Free Trial
Pohl Boskamp NITRO IV nitroglycerin INJECTABLE;INJECTION 018672-002 Aug 30, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Pohl Boskamp NITRONAL nitroglycerin INJECTABLE;INJECTION 018672-001 Aug 30, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Pohl Boskamp NITROLINGUAL nitroglycerin AEROSOL;SUBLINGUAL 018705-001 Oct 31, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Pohl Boskamp GONITRO nitroglycerin POWDER;SUBLINGUAL 208424-001 Jun 8, 2016 RX Yes Yes 9,101,592 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for POHL BOSKAMP drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Sublingual Spray 400 mcg/spray, 4.9 g and 12 g bottles ➤ Subscribe 2012-08-23
➤ Subscribe Sublingual Spray 400 mcg/spray, 4.9 g and 12 g bottles ➤ Subscribe 2012-04-17

Non-Orange Book US Patents for Pohl Boskamp

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,616,023 Stabilized granules containing glyceryl trinitrate ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Pohl Boskamp Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Johnson and Johnson
Express Scripts
Dow
McKesson
Cantor Fitzgerald
Deloitte
Covington
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.